Press Releases

Landmark 24‑Month Data Show DOT™ Lenses Save More than 1D of Myopia Progression in Young Children

14 May 2026

SightGlass Vision Launches “Control the Contrast” Professional Education Campaign for Myopia Control

11 May 2026

Studies Presented at NCC Can Reinforce Prescriber Confidence in DOT™ Spectacle Lenses for Myopia Control

30 April 2026

SightGlass Vision Strengthens Leadership in Myopia Control with New Medical and Professional Affairs Appointments

8 April 2026

MEDIA ALERT: Expert Lecture Explores Contrast Management for Myopia Control at 100% Optical

3 March 2026

SightGlass Vision Expands Canada Team to Elevate DOT™ Spectacle Lens Awareness and Education

23 February 2026

SightGlass Vision Names Natalia Trela-McDonald as Head of Research and Development

1 December 2025

Academy ’25: DOT™ Spectacle Lens 18-Month Data Affirm Powerful Myopia Control

10 October 2025

DOT™ Myopia Control Spectacle Lenses Available for Early Access in the U.K.

29 September 2025

DOT™ Lenses Worn by One Million Children

25 August 2025

New Studies Demonstrate 75% Myopia Management Efficacy with Chinese Children after 12 Months and No Evidence of Rebound Effect in North American Children for SightGlass Vision DOT™ Lenses

5 May 2025

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

9 December 2024

Please note that our products are not available for sale or distribution in every country in the world.
Our products are not available for sale in the U.S.